← Back to headlines
Barclays Maintains Favorable Long-Term Outlook for Legend Biotech Despite Near-Term Revisions
Barclays has reiterated a positive long-term outlook for Legend Biotech Corporation, even as it revises near-term expectations for the company.
18 Feb, 07:03 — 18 Feb, 07:03
ℹOnly 1 source covers this story
